"Specialized care for cancer and blood disorders is close by with Northwest Georgia Oncology Centers — a service of Tanner Medical Center/Villa Rica, with offices in Carrollton, Villa Rica and Bremen. Our board-certified medical oncology and hematology specialists provide access to advanced chemotherapy and immunotherapy treatments using the latest pharmaceuticals available to hospitals. With Northwest Georgia Oncology Centers and Tanner Cancer Care, you have a full range of treatment options — including surgical care, radiation therapy and a host of support services."

During the past decade, Northwest Georgia Oncology Centers, P.C. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Georgia Oncology Centers, P.C." #1 collaborator was "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Georgia Oncology Centers, P.C." are "Non-Small Cell Lung Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Prostate Cancer" (1 trials), "Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Northwest Georgia Oncology Centers, P.C." in a lesser frequency.

Most popular intervention types in "Northwest Georgia Oncology Centers, P.C." are "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Active Comparator (erlotinib)" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Georgia Oncology Centers, P.C." are 3 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northwest Georgia Oncology Centers, P.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Northwest Georgia Oncology Centers, P.C., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Georgia Oncology Centers, P.C., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".